Investigational Drug Details
| Drug ID: | D494 |
| Drug Name: | Silibinin |
| Synonyms: | |
| Type: | small molecule |
| DrugBank ID: | DB09298 |
| DrugBank Description: | Silibinin is the major active constituent of silymarin, a standardized extract of the milk thistle seeds, containing a mixture of flavonolignans consisting of silibinin, isosilibinin, silicristin, silidianin and others. Silibinin is presented as a mixture of two diastereomers, silybin A and silybin B, which are found in an approximately equimolar ratio. Both in vitro and animal research suggest that silibinin has hepatoprotective (antihepatotoxic) properties that protect liver cells against toxins. Silibinin has also demonstrated in vitro anti-cancer effects against human prostate adenocarcinoma cells, estrogen-dependent and -independent human breast carcinoma cells, human ectocervical carcinoma cells, human colon cancer cells, and both small and nonsmall human lung carcinoma cells. |
| PubChem ID: | 31553 |
| CasNo: | 22888-70-6 |
| Repositioning for NAFLD: | Yes |
| SMILES: | [H][C@@]1(OC2=C(O[C@@H]1CO)C=CC(=C2)[C@@]1([H])OC2=C(C(O)=CC(O)=C2)C(=O)[C@@H]1O)C1=CC(OC)=C(O)C=C1 |
| Structure: |
|
| InChiKey: | SEBFKMXJBCUCAI-HKTJVKLFSA-N |
| Molecular Weight: | 482.441 |
| DrugBank Targets: | |
| DrugBank MoA: | |
| DrugBank Pharmacology: | |
| DrugBank Indication: | Currently being tested as a treatment of severe intoxications with hepatotoxic substances, such as death cap (Amanita phalloides) poisoning. |
| Targets: | |
| Therapeutic Category: | |
| Clinical Trial Progress: | |
| Latest Progress: |
| Trial ID | Source ID | Phases | Status | Study Results | Start Date | Last Update Posted |
|---|
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
|---|
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|
| Article ID | PMID | Source | Title |
|---|